Kathleen Ludwig

Statistics

Publications

Citations

427

H-Index

Active since

2015

Affiliations

The University of Texas Southwestern Medical Center(Current)

Johns Hopkins University

Children's Hospital of Philadelphia

University of Bergen

University of Pennsylvania

Kathleen Ludwig is an author at The University of Texas Southwestern Medical Center specializing in oncology, medicine, and tyrosine kinase inhibitors.

Publications per year

2015–2025

Publications

Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis

Amanda Kirane, Kathleen Ludwig, Noah Sorrelle et al. · Cancer Research · 2015 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer

Kathleen Ludwig, Wenting Du, Noah Sorrelle et al. · Cancer Research · 2017 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Giant Congenital Melanocytic Nevus Treated With Trametinib

Adnan Mir, Nnenna G. Agim, Alex A. Kane et al. · PEDIATRICS · 2019 · 59 citations

Medicine, Dermatology, Oncology +17

Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

Hiroto Inaba, David T. Teachey, Colleen Annesley et al. · Journal of the National Comprehensive Cancer Network · 2025 · 20 citations

Medicine, Oncology, Pediatrics +13

Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric <i>NTRK</i> Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823)

Theodore W. Laetsch, Stephan D. Voss, Kathleen Ludwig et al. · Journal of Clinical Oncology · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 7